Oxidized proteins in plasma of patients with heart failure: Role in endothelial damage

European Journal of Heart Failure

Volumn 10, Issue 3, 2008, Pages 244-251

  Banfi, Cristina ^a,b   Brioschi, Maura ^a,b   Barcella, Simona ^a,b   Veglia, Fabrizio ^a   Biglioli, Paolo ^a,b   Tremoli, Elena ^a,b   Agostoni, PierGiuseppe ^a,b  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

1 antitrypsin; Apoptosis; Endothelium; Fibrinogen; Heart failure

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ELASTASE; FIBRINOGEN; IMMUNOGLOBULIN; PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM LESION; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS;

AGED; ALPHA 1-ANTITRYPSIN; CELL SURVIVAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEOMICS;

EID: 40249113132     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.01.016     Document Type: Article

References (31)

1. Giordano F. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115 (2005) 500-508
2. Ghatak A., Brar M.J., Agarwal A., et al. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol 57 (1996) 119-127
3. Keith M., Geranmayegan A., Sole M.J., et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 1352-1356
4. Mallat Z., Philip I., Lebret M., Chatel D., Maclouf J., and Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97 (1998) 1536-1539
5. Sobotka P.A., Brottman M.D., Weitz Z., Birnbaum A.J., Skosey J.L., and Zarling E.J. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radic Biol Med 14 (1993) 643-647
6. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., and Milzani A. Protein carbonylation in human diseases. Trends Mol Med 9 (2003) 169-176
7. Berlett B.S., and Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272 (1997) 20313-20316
8. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233 (1994) 346-357
9. Conrad C.C., Choi J., Malakowsky C.A., et al. Identification of protein carbonyls after two-dimensional electrophoresis. Proteomics 1 (2001) 829-834
10. Banfi C., Brioschi M., Wait R., et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 5 (2005) 4443-4455
11. Banfi C., Camera M., Giandomenico G., et al. Vascular thrombogenicity induced by progressive LDL oxidation: protection by antioxidants. Thromb Haemost 89 (2003) 544-553
12. Rottoli P., Magi B., Cianti R., et al. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 5 (2005) 2612-2618
13. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., and Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329 (2003) 23-38
14. Siems W.G., Zollner H., Grune T., and Esterbauer H. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J Lipid Res 38 (1997) 612-622
15. Pantke U., Volk T., Schmutzler M., Kox W.J., Sitte N., and Grune T. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic Biol Med 27 (1999) 1080-1086
16. Griffiths H.R. Antioxidants and protein oxidation. Free Radic Res 33 (2000) 47-58
17. Friguet B., Szweda L.I., and Stadtman E.R. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys 311 (1994) 168-173
18. Butterfield D.A., Hensley K., Cole P., et al. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem 68 (1997) 2451-2457
19. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915-924
20. Kalsheker N.A. Molecular pathology of alpha 1-antitrypsin deficiency and its significance to clinical medicine. QJM 87 (1994) 653-658
21. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
22. Moraga F., and Janciauskiene S. Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin. J Biol Chem 275 (2000) 7693-7700
23. Mannucci P.M. Recent progress in the pathophysiology of fibrinogen. Eur Heart J 16 (1995) 25-30
24. Bombeli T., Schwartz B.R., and Harlan J.M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule-1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187 (1998) 329-339
25. Stief T.W., Marx R., and Heimburger N. Oxidized fibrin(ogen) derivatives enhance the activity of tissue type plasminogen activator. Thromb Res 56 (1989) 221-228
26. Azizova O.A., Maksyanina E.V., Romanov Y.A., Aseichev A.V., and Scheglovitova O.N. Fibrinogen and its oxidized form induce interleukin-8 production in cultured endothelial cells of human vessels. Bull Exp Biol Med 137 (2004) 358-360
27. Katz S.D. Mechanisms and implications of endothelial dysfunction in congestive heart failure. Curr Opin Cardiol 12 (1997) 259-264
28. Agnoletti L., Curello S., Bachetti T., et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation 100 (1999) 1983-1991
29. Ferrari R., Curello S., Bachetti T., et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92 (1995) 1479-1486
30. Hirsch A.T., Pinto Y.M., Schunkert H., and Dzau V.J. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 66 (1990) 22-30
31. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complications 15 (2001) 203-210